Today’s stock pick update – Open Now

Learn More

You Could Make $300 to $1100 Per Contract With This Simple Trade

Imagine getting really good at mastering just ONE simple trade. A trade that appears like clockwork between 9:30-10:45am on most trading days. This free step-by-step guide, by options expert, Dave Acquino, shows you how to spot and take these trades so you can walk away with daily profits!(Ad)

CLICK HERE for instant access.

Walmart Is Teaming Up With Instacart For Grocery Delivery In Battle Against Amazon

Russian President Vladimir Putin announced today that Russia’s health authorities have approved what the country claims is the world’s first vaccine for the coronavirus. “As far as I know, a vaccine against a new coronavirus infection has been registered this morning, for the first time in the world,” Putin said. “Although I know that it works quite effectively, it forms a stable immunity and, I repeat, has passed all the necessary checks.” Mass production of the ...

Read More

Seres Therapeutics (NASDAQ: MCRB): Seres shares skyrocketed 389% yesterday after the biotech announced positive topline results form its pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI), a bacterial infection of the colon that leads to inflammation and can be deadly. “We are extremely p...

Read More

KR might not be sexy – but it is both timely and a terrific value

The herd mentality is a big reason why pandemic-driven concerns since March have driven most of the market’s attention to stocks in the Technology and Healthcare sector. That doesn’t mean it’s wrong – but it’s one of the biggest reasons that a lot of tech stocks are now trading a valuations that even the most bullish, growth-focused analysts are finding hard to justify. Herd mentality that drives stocks to extreme highs is a manifestation of investor’s tendency to want to inve...

Read More

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease vaccines using its Self-Transcribing and Replicating RNA (STARR) technology.


Read More

Already subscribed to our premium service?

Click here to Login.

Not a TradersPro subscriber yet?

Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits




This email was sent to phanhoa1821960.trader@blogger.com 
by TradersPro Investiv, LLC
265 N. Main | Ste. D #283
Kaysville | UT | 84037

Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro
 
All trading carries significant risk. Please see our full risk disclaimer.


Disclaimers, Terms & Conditions | Privacy Policy

Copyright © 2020

 

No comments:

Post a Comment